Developing Technology for the Future and Delivering viable Solutions TodayTamarisk Technologies is revolutionizing industries with it's cutting edge solutions.
Serum-Specific Drug Transport Vehicle, Oral RouteOur New Drug Delivery Technology Delivers up to 95% of the therapeutic payload... Now Available
Tissue Specific Drug Delivery Vehicle"Once in a lifetime, a technology comes along with the true potential to change the world. This is one of those technologies" Now Available
Rapidly Biodegradable Plastics are Here!Our new plastic is biodegradable in 60 days... another ground-breaking technology developed by Tamarisk Technologies. Now Available
The Tamarisk Revolution Has BegunIt is said, "there is an appointed time for everything. And there is a time for every event under heaven." Well, this is the time for Tamarisk.
In 2011, Tamarisk assigned it's SSNe patent and related technologies to its licensing arm, DelivRx, Inc., a Nevada corporation in which Tamarisk has acquired 70% ownership. DelivRx is actively engaged in working with major pharmaceutical and related companies to license the technology for utilization over a broad panoply of applications.
For more information about Tamarisk's Serum Specifc, Tissue Specific, and Extended Release technologies, contact the DelivRX team today at firstname.lastname@example.org or call our office at 405-279-1250.
Serum-Specific Drug Transport- Click Here
Oral Insulin Report- Click Here
Oral Peptide YY 3-36 - Click Here
Oral Tumore Necrosis Factor - Coming Soon
Oral Herceptin - Coming Soon
Oral Pegylated Interferon - Coming Soon
The documents on this web site could include technical inaccuracies or typographical errors. Please report any errors to Tamarisk Technologies Customer Service